ASX - Delayed Quote AUD

TrivarX Limited (TRI.AX)

0.0260 0.0000 (0.00%)
At close: April 26 at 3:28 PM GMT+10
Key Events
Loading Chart for TRI.AX
DELL
  • Previous Close 0.0260
  • Open 0.0260
  • Bid 0.0260 x --
  • Ask 0.0300 x --
  • Day's Range 0.0250 - 0.0260
  • 52 Week Range 0.0200 - 0.0420
  • Volume 2,035,518
  • Avg. Volume 554,484
  • Market Cap (intraday) 8.8M
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Feb 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

trivarx.com

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: TRI.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TRI.AX
13.33%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

TRI.AX
0.00%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

TRI.AX
83.75%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

TRI.AX
92.78%
S&P/ASX 200 [XJO]
18.64%

Compare To: TRI.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRI.AX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    8.80M

  • Enterprise Value

    8.55M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.05

  • Enterprise Value/Revenue

    387.36

  • Enterprise Value/EBITDA

    -2.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -16.89%

  • Return on Equity (ttm)

    -47.15%

  • Revenue (ttm)

    19.42k

  • Net Income Avi to Common (ttm)

    -3.74M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    310.82k

  • Total Debt/Equity (mrq)

    0.72%

  • Levered Free Cash Flow (ttm)

    -3.74M

Company Insights: TRI.AX

People Also Watch